Quote | Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX)
Last: | $0.63 |
---|---|
Change Percent: | -5.68% |
Open: | $0.668 |
Close: | $0.63 |
High: | $0.6897 |
Low: | $0.6036 |
Volume: | 239,320 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX)
2024-03-14 12:57:03 ET Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Conference Call March 14, 2024, 8:30 AM ET Company Participants Gordon Dunn - Chief Financial Officer Michael Myers - Chief Executive Officer Conference Call Participants Nazibur R...
2024-03-13 16:21:32 ET More on Quoin Pharmaceuticals Quoin stock craters 47% on public offering after rallying in prior session Quoin stock soars 60% on FDA update for ichthyosis drug Seeking Alpha’s Quant Rating on Quoin Pharmaceuticals Historical ear...
Message Board Posts | Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX)
Subject | By | Source | When |
---|---|---|---|
Price gaining last trade up | 1968cuda434 | investorshub | 04/30/2023 9:56:08 AM |
$QNRX The now last up | TIMGZ | investorshub | 04/28/2023 9:44:52 PM |
Price now | crudeoil24 | investorshub | 04/27/2023 5:19:19 PM |
$QNRX Thoughts on where this is headed? | reena969 | investorshub | 04/26/2023 4:30:15 PM |
Do we have a winner?Turn around time? | Tadaia | investorshub | 04/26/2023 8:54:32 AM |
News, Short Squeeze, Breakout and More Instantly...
Quoin Pharmaceuticals Ltd. Company Name:
QNRX Stock Symbol:
NASDAQ Market:
Company reported positive initial clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study with positive benefits observed across a number of clinical endpoints Eligibility age for enrollment into both studies has been lowered to fourteen...
SuRo Capital Corp. (SSSS) is expected to report for quarter end 2023-12-31 Enviva Inc. (EVA) is expected to report $-0.76 for Q4 2023 Jushi Holdings Inc. - Class B (Sub Voting) (JUSHF) is expected to report $-0.04 for Q4 2023 U Power Limited (UCAR) is expected to report for quarter en...
ASHBURN, Va., March 07, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a clinical stage specialty...